Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients

被引:68
作者
Wang, Yunjun [1 ,2 ]
Guan, Qing [1 ,2 ]
Xiang, Jun [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Head & Neck Surg, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
关键词
Papillary thyroid carcinoma; Microcarcinoma; Central lymph node metastasis; Nomogram; BRAF(V600E) MUTATION; RISK-FACTORS; CARCINOMA; CANCER; RECURRENCE; DISSECTION; MANAGEMENT; DIAGNOSIS; STRATEGY; SURGERY;
D O I
10.1016/j.ijsu.2018.05.023
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: The status of central lymph node metastasis (CLNM) is crucial to determining the surgical strategies for papillary thyroid micro carcinoma (PTMC). The objective of the study was to establish a nomogram to predict the possibility of CLNM in PTMC patients. Methods: A total of 8668 PTMC patients who underwent total thyroidectomy or lobectomy with central lymph node dissection (CLND) from 2006 to 2016 were retrospectively retrieved. Univariate and multivariate analysis were performed to examine risk factors associated with CLNM. A nomogram for predicting CLNM was established and internally validated. Results: Six variables significantly associated with CLNM were included in our model, these are age < 55 years (odd ratio [OR] = 1.779, 95% confidence interval [CI], 1.569-2.017; P < 0.001), male sex (OR = 1.718, 95% CI, 1.543-1.913; P < 0.001), tumor size 0.5-1.0 cm (OR = 1.985,95% CI, 1.761-2.238; P < 0.001), multi-focal lesions (OR = 1.263, 95% CI, 1.118-1.426; P < 0.001), extra thyroidal extension (ETE) (OR = 1.348, 95% CI, 1.092-1.664; P = 0.005) and lateral lymph node metastasis (LLNM) (OR = 5.135, 95% CI, 4.236-6.225; P < 0.001). The discrimination of the prediction model was 0.711 (95% CI, 0.700-0.722; P < 0.001). Conclusions: Based on the quantified risk stratification offered by our nomogram, clinicians might have a thorough discussion with PTMC patients during the both pre- and postoperative period. Prophylactic CLND and strict postoperative evaluation may be indicated when the patients have a high nomogram score.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 37 条
[1]   The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery [J].
Agha, Riaz Ahmed ;
Borrelli, Mimi R. ;
Vella-Baldacchino, Martinique ;
Thavayogan, Rachel ;
Orgill, Dennis P. .
INTERNATIONAL JOURNAL OF SURGERY, 2017, 46 :198-202
[2]   BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma [J].
Bastos, Andre Uchimura ;
Oler, Gisele ;
Nakano Nozima, Bruno Heidi ;
Moyses, Raquel Ajub ;
Cerutti, Janete Maria .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (04) :525-540
[3]   Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology [J].
Burgess, JR ;
Tucker, P .
THYROID, 2006, 16 (01) :47-53
[4]   Should central lymph node dissection be considered for all papillary thyroid microcarcinoma? [J].
Chang, Young Woo ;
Kim, Hwan Soo ;
Kim, Hoon Yub ;
Lee, Jae Bok ;
Bae, Jeoung Won ;
Son, Gil Soo .
ASIAN JOURNAL OF SURGERY, 2016, 39 (04) :197-201
[5]   BRAFV600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis [J].
Chen, Yufei ;
Sadow, Peter M. ;
Suh, Hyunsuk ;
Lee, Kyu Eun ;
Choi, June Young ;
Suh, Yong Joon ;
Wang, Tracy S. ;
Lubitz, Carrie C. .
THYROID, 2016, 26 (02) :248-255
[6]   Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia [J].
Cho, Soo Youn ;
Lee, Tae Hyun ;
Ku, Yun Hyi ;
IlKim, Hong ;
Lee, Guk Haeng ;
Kim, Min Joo .
SURGERY, 2015, 157 (01) :111-118
[7]   Papillary microcarcinoma of the thyroid - Prognostic significance of lymph node metastasis and multifocality [J].
Chow, SM ;
Law, SCK ;
Chan, JKC ;
Au, SK ;
Yau, S ;
Lau, WH .
CANCER, 2003, 98 (01) :31-40
[8]   Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy [J].
Crescenzi, A. ;
Trimboli, P. ;
Modica, D. Cicciarella ;
Taffon, C. ;
Guidobaldi, L. ;
Taccogna, S. ;
Rainer, A. ;
Trombetta, M. ;
Papini, E. ;
Zelano, G. .
HORMONE AND METABOLIC RESEARCH, 2016, 48 (03) :157-162
[9]   Immunohistochemistry for BRAF(V600E) Antibody VE1 Performed in Core Needle Biopsy Samples Identifi es Mutated Papillary Thyroid Cancers [J].
Crescenzi, A. ;
Guidobaldi, L. ;
Nasrollah, N. ;
Taccogna, S. ;
Modica, D. D. Cicciarella ;
Turrini, L. ;
Nigri, G. ;
Romanelli, F. ;
Valabrega, S. ;
Giovanella, L. ;
Muda, A. Onetti ;
Trimboli, P. .
HORMONE AND METABOLIC RESEARCH, 2014, 46 (05) :370-374
[10]   Increasing incidence of thyroid cancer in the United States, 1973-2002 [J].
Davies, L ;
Welch, HG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (18) :2164-2167